Department of General Surgery, Second Afflliated Hospital of Nanchang University, Nanchang, China.
Department of Endocrinology and Metabolism, Shanghai Clinical Center for Endocrine and Metabolic Diseases, Shanghai Institute of Endocrine and Metabolic Diseases, Ruijin Hospital, China National Research Center for Metabolic Diseases, Shanghai Jiao Tong University School of Medicine, China.
Mol Cell Endocrinol. 2020 Dec 1;518:111037. doi: 10.1016/j.mce.2020.111037. Epub 2020 Sep 20.
Ubiquitin-specific protease 7 (USP7/HAUSP) is known to regulate multiple cellular phenomena, including cell cycle progression and proliferation, and is involved in binding and stabilizing specific target proteins through deubiquitylation. However, the detailed role of USP7 in papillary thyroid carcinoma (PTC) remains to be investigated. In this study, our results showed that USP7 was upregulated in PTC tissues compared with adjacent nontumour tissues. Consistently, a series of gain/loss functional assays in vivo and in vitro demonstrated the role of USP7 in promoting PTC cell proliferation. Furthermore, we showed that there was a negative correlation between USP7 and the CDK inhibitor p57 expression in PTC tissues and that USP7 facilitated PTC cell proliferation by inhibiting p57. Mechanistically, USP7 inhibited p57 expression by modulating TBX3, directly binding to TBX3, and decreasing its ubiquitination and degradation. Our findings demonstrated that USP7 played a critical oncogenic role in PTC tumorigenesis, suggesting that USP7 might act as a prognostic and therapeutic target for PTC progression.
泛素特异性蛋白酶 7(USP7/HAUSP)已知可调节多种细胞现象,包括细胞周期进程和增殖,并通过去泛素化参与结合和稳定特定的靶蛋白。然而,USP7 在甲状腺乳头状癌(PTC)中的详细作用仍有待研究。在这项研究中,我们的结果表明,与相邻非肿瘤组织相比,USP7 在 PTC 组织中上调。一致地,体内和体外的一系列获得/缺失功能测定表明 USP7 在促进 PTC 细胞增殖中发挥作用。此外,我们表明,在 PTC 组织中,USP7 与 CDK 抑制剂 p57 的表达呈负相关,USP7 通过抑制 p57 促进 PTC 细胞增殖。在机制上,USP7 通过调节 TBX3、直接与 TBX3 结合以及减少其泛素化和降解来抑制 p57 的表达。我们的研究结果表明,USP7 在 PTC 肿瘤发生中发挥了关键的致癌作用,提示 USP7 可能成为 PTC 进展的预后和治疗靶点。